Kardashian is joining the New Haven, Connecticut-based company's "Take Back Today" campaign, aimed at promoting the recently-launched orally dissolving tablet for people suffering from migraines.
The 36-year old, of the "Keeping Up with the Kardashians" fame, said in a statement that she has been taking the drug, and it has proved "different than other treatments."
The drug "worked fast and allowed me to get back to normal so that I could take back my day. I'm sharing my story so others with migraine do not feel alone and can be empowered to Take Back Today from migraine," she added.
Why It Matters
Nurtec ODT had received the United States Food and Drug Administration approval to treat migraines in February.
Biohaven claims that a single dose of the drug "can provide fast pain relief and return patients to normal function within one hour, and deliver sustained efficacy that lasts up to 48 hours for many patients."
The pharmaceutical's choice for tapping Kardashian comes as it says a majority of the 40 million people who have migraines are women.
Biohaven shares closed 4.8% higher at $76.39 on Wednesday. The shares traded 1.1% lower at $75.55 in the after-hours session.
Photo credit: Eric Longden, via Wikimedia Commons
See more from Benzinga
- GoHealth Shares Drop 9% On Day One Trading After 3M IPO
- Apple Device Management Software Maker Jamf Plans To Raise Up To 4M In IPO
- Biopharmaceutical Company Nkarta Raises 0M In IPO
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.